3 Great Reasons Why Aviva plc Is Set To Take Off

Royston Wild looks at the major share price drivers for Aviva plc (LON: AV).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Today I am looking at why I believe Aviva (LSE: AV) (NYSE: AV.US) is an intriguing proposition for investors chasing high-risk stocks with potentially lucrative rewards.

A tempting all-round selection

Aviva is a popular pick for investors seeking strong total shareholder returns. City analysts expect the company’s recovery strategy to yield earnings of 42.2p per share in 2013, swinging from losses per share of 15.2p last year. And earnings are predicted to rise an additional 10% in 2014 to 46.5p.

These projections leave the company dealing on a P/E rating of 9.7 and 8.8 for 2013 and 2014 respectively, entrenched within the bargain area below 10 and suggesting that the firm is due a positive re-rating. A significantly higher forward reading of 14.2 for the whole life insurance sector backs up this theory.

Additionally, Aviva is also touted to produce above-average dividend yields for this year and next, even if the business’ decision to rebase the dividend in March — and consequent effect on future payouts — is likely to result in a further drop in the final payout this year. A payout of 15.5p is expected for 2013 versus 19p in 2012, although dividends are expected to resume an upward path next year, to 16.5p.

Still, the insurer currently carries dividend yields of 4% and 4.2% for this year and next, comfortably above the 3.2% FTSE 100 average. I am expecting yields to tick higher further ahead as earnings gradually improve.

New business continues to take off

Aviva announced last month that the value of new business across the group jumped 17% in January-June, to £401m. This was underpinned by a 16% rise in new business value in the UK and Ireland, to £211m, although performance in its markets abroad remains patchy.

Still, Aviva has concocted a plan to resuscitate operations at its underperforming Italian, Spanish, Irish and Aviva Investors divisions, while it is also looking to charge activity in the exciting markets of South East Asia, China, Poland and Turkey to underpin future growths.

Cost reduction plans making hay

Aviva’s cost-reduction scheme also continues to yield rich fruit. Operating expenses dropped an impressive 9% in January-June, to £1.53bn.

And the firm believes that it is in good shape to deliver additional cost savings, achieved through its strategic focus towards digital and automation, while significantly lower restructuring costs through to end-2014 should also boost earnings. These costs dropped 10% in the first six months of 2013, to £164m.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

> Royston does not own shares in Aviva.

More on Investing Articles

Fans of Warren Buffett taking his photo
Investing For Beginners

This billionaire is copying Warren Buffett. Should I do the same?

Jon Smith reviews fresh news about how an investment billionaire is imitating Warren Buffett as he goes after an interesting…

Read more »

Investing Articles

I expect these 3 FTSE 100 shares to fly when inflation really starts to fall

Harvey Jones picks out three FTSE 100 shares whose fortunes should improve once inflation is finally on the run. They're…

Read more »

Investing Articles

After a positive Q4 update, is the Vistry share price set to bounce back?

The Vistry share price has been falling sharply as a result of cost issues in its South Division. But the…

Read more »

Investing Articles

Is it game over for the Diageo share price?

The Diageo share price is showing as much spirit as an alcohol-free cocktail. Harvey Jones is wondering whether he should…

Read more »

Young Caucasian girl showing and pointing up with fingers number three against yellow background
Investing Articles

3 key reasons why AstraZeneca’s share price looks a steal to me right now

AstraZeneca’s share price has fallen a long way from its record-breaking level last year, which indicates that I may be…

Read more »

Investing Articles

Here’s how investors could aim for a £6,531 annual passive income from £11,000 of Aviva shares

As a stock’s yield rises when its price falls, I'm not bothered by Aviva shares’ apparent inability to break the…

Read more »

Investing Articles

3 million reasons why earning a second income is more important than ever

With AI posing a threat to UK jobs, our writer considers ways to earn a second income by investing in…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

With an 8% yield, is the second-largest FTSE 250 stock worth considering?

Our writer considers the value of the second-largest stock on the FTSE 250 with a £4bn market cap and a…

Read more »